AI-Based Mobile Intervention on Medication Non-Adherence and Transition

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
Epistemonikos ID: 16398c766099bed3e195f5950cb91d3c9853b20a
First added on: Mar 04, 2026